Dynavax Technologies Corporation (Nasdaq: DVAX), a fully-integrated biopharmaceutical company focused on discovering, developing and commercializing novel vaccines, today announced that ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
